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Abstract
Ocular surgeries and trauma predispose the eye to develop infectious endophthalmitis, which often leads to vision loss. The
mechanisms of initiation of innate defense in this disease are not well understood but are presumed to involve retinal glial
cells. We hypothesize that retinal Muller glia can recognize and respond to invading pathogens via TLRs, which are key
regulators of the innate immune system. Using the mouse retinal sections, human retinal Muller cell line (MIO-M1), and
primary mouse retinal Muller cells, we show that they express known human TLR1-10, adaptor molecules MyD88, TRIF,
TRAM, and TRAF6, and co-receptors MD2 and CD14. Consistent with the gene expression, protein levels were also detected
for the TLRs. Moreover, stimulation of the Muller glia with TLR 2, 3, 4, 5, 7 and 9 agonists resulted in an increased TLR
expression as assayed by Western blot and flow cytometry. Furthermore, TLR agonists or live pathogen (S. aureus, P.
aeruginosa,&C. albicans)-challenged Muller glia produced significantly higher levels of inflammatory mediators (TNF-a, IL-
1b, IL-6 and IL-8), concomitantly with the activation of NF-kB, p38 and Erk signaling. This data suggests that Muller glia
directly contributes to retinal innate defense by recognizing microbial patterns under infectious conditions; such as those in
endophthalmitis.
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Introduction
Glial cells are found throughout the central nervous system
(CNS). In the mammalian retina, three types of glia have been
identified: Muller glia, astroglia or astrocytes, and microglia.
Muller cells are the predominant glial cell type in the retina and
have a unique anatomy with processes that span the entire retinal
thickness, forming the retinal margins at the internal (ILM) and
outer (OLM) limiting membranes retina [1,2]. They surround
neuronal cell bodies and processes within the retina and perform a
wide range of functions, including structural stabilization,
regulation of ion homeostasis, neurotransmitter recycling, and
neuronal survival [2,3,4,5]. Thus, the primary role of Muller glia is
to maintain retinal neuronal health [6,7]. However, when retinal
homeostasis is perturbed as a result of trauma, neurodegeneration,
inflammatory disease, or excitotoxicity, Muller glia becomes
activated and undergo reactive gliosis [6]. The characteristics of
Muller gliosis include cellular hypertrophy, upregulation of glial
fibrillary acidic protein (GFAP) and the intermediate filament,
vimentin [7]. Although virtually every retinal disease is associated
with a reactive Muller gliosis, little is known about Muller glial
innate response in infectious diseases of the retina. Considering
their strategic location and predominance, it may therefore be
postulated that Muller glia are more likely to encounter microbes
than other cells. Thus, we hypothesized that Muller cells play an
important role in defending the retina from infectious insults via
the action of Toll-like receptors (TLRs).
Toll-like receptors (TLRs) are a family of evolutionarily
conserved pattern recognition receptors that recognize microbi-
al-associated molecular patterns (MAMPs) from diverse organisms,
including bacteria, viruses, fungi, and parasites [8]. Currently, 13
TLRs have been identified: TLRs 1–9 are common to mouse and
human, TLR 10 is only found in humans, and TLRs 11–13 are
unique to the mouse [9]. Activation of TLRs on immune cells by
pathogens or their products initiate the innate response charac-
terized by the expression of proinflammatory mediators and anti-
microbial effector molecules [10]. TLRs also recognize endoge-
nous ligands termed as damage-associated molecular patterns
(DAMPs), and mediate the host’s inflammatory response to injury
and stress [11]. The initial inflammatory responses mediated by
TLRs are required for host defense against invading pathogens
and tissue repair. However, exaggerated or chronic inflammation
induced by activation of these receptors may also lead to tissue
damage and development of autoimmune disorders [12].
Several studies have demonstrated the expression of TLRs in
various cell types in the CNS, including microglia, astrocytes,
neurons, and vascular endothelial cells [13]. Accumulating
evidence supports that TLRs play a major role in brain infection
and injury, and are involved in autoimmune neuropathy and
neurodegenerative disorders [12,14,15,16]. Since, the retina is a
part of CNS, it is logical to propose that similar to the brain,
retinal glial cells also express TLRs. Although, few recent studies
from our [17,18] and other laboratories have documented the
expression of TLRs in the retina [19,20,21], relatively little is
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e29830known about the role of TLR signaling, particularly in infectious
endophthalmitis. Moreover, to our knowledge, a full character-
ization of TLR expression and responsiveness to TLR ligands in
retinal Muller glia has not previously been carried out. In the
present study, we have investigated the recognition and initiation
of Muller glial innate response by TLR ligands and live pathogens.
Our data demonstrates the expression of all TLRs by Muller glia,
which enables the detection of both Gram-positive, Gram-negative
bacteria and fungal pathogens. These findings emphasize the
potentially important role the Muller glia plays in regulating
retinal innate defense.
Results
Retinal Muller glia express Toll-like receptors
TLRs are known to play a key role in initiation of early innate
responses [22]. We hypothesized that in the case of endophthal-
mitis, retinal Muller glia recognize infectious stimuli via TLR
signaling and focused our attention assessing their role in Muller
glial innate response. First, we performed an immunohistochem-
ical analysis to determine the cellular localization of TLRs in the
mouse retina. Double immunofluorescence labeling of the retina
sections using specific antibodies to key TLRs (TLR 2, 3, 4, 5, 7
and 9) as well as the cell markers for the Muller cells revealed that
all of the six TLRs studied co-localize with radially running
vimentin positive cells, an indication of Muller glia (Fig. 1A). To
confirm the expression of TLRs specifically in Muller glia, we
performed RT-PCR analysis on the spontaneously immortalized
human retinal Muller glia cells line, MIO-M1 [23]. As shown in
Figure 1B, MIO-M1 cells express all human TLRs (TLR1 to 10);
additionally, they were also found to express co-receptors (MD2
and CD14) and adaptor molecules (TRIF, TRAM, TRAF-6, and
MyD88). All amplified products were of predicted size for their
respective genes as is evident by running parallel PCR with cDNA
from a human monocytic cell line (THP-1), which is known to
express all TLRs [24]. Thus, we conclude that retinal Muller glia
express TLRs.
Stimulated retinal Muller glia exhibited increased TLR
expression levels
The previous results indicated that retinal Muller glia express
TLRs at basal levels. To determine whether their expression is
altered following stimulation, MIO-M-1 cells were challenged with
TLR ligands, and their respective TLR expression was assessed by
Western blot, immunohistochemistry, and flow cytometry analysis.
Clearly, stimulation of MIO-M1 cells by indicated TLR ligands
for 4 h up-regulated the protein levels of TLR2, 3, 4, 5, 7 and 9
(Fig. 2A). The semi-quantitative analysis by measuring band
intensities revealed dramatic increases in levels of TLR2 and 9
compared to others (Fig. 2B). In order to ascertain the induced
expression of TLRs, we performed immunohistochemistry of
stimulated Muller glia using anti TLR antibodies. Consistently,
our immunofluorescence data also showed the expression and
upregulation of various TLRs in Muller glia (Fig. 2C). Since
immunofluorescence is not a quantitative method, we performed
flow cytometry analysis. To this end, our data showed induced
TLR expression, and marked increases in MFI values were
observed for TLR3, 4 and 9 (Fig. 2D). Taken together, these
results suggest that infectious stimuli elicit TLR expression in
retinal Muller glia.
Figure 1. In vivo and in vitro expression of TLRs in retinal Muller glia. (A) Eyes from C57BL/6 mice were enucleated and embedded in OCT,
and cryo-sections were stained with indicated TLR antibodies. Double immunofluorescence labeling was performed using anti-TLR 2, 3, 4, 5, 7 and 9
(green) antibodies and anti-vimentin (red) antibody, a marker for Muller glia cells. TLRs expression co-localizes to Muller glia, as the Muller cell bodies
and radial running processes were immunopositive. (B) To assess the expression of TLRs, other co-receptors, and adaptor molecules, RNA extraction
followed by RT-PCR was performed on cultured human retinal Muller glia cell line (MIO-M1) and human monocyte cell line (THP-1), as a positive
control. Results shown are representative of two experiments with similar results. GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear
layer. Magnification 206.
doi:10.1371/journal.pone.0029830.g001
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in retinal Muller glia
The induced expression of different TLRs following stimulation
suggests that TLR downstream signaling might also be activated in
Muller glia. To test this, MIO-M1 cells were challenged with
ligands for TLR2, 3, 4, 5, 7 and 9, and the activation of p38 and
Erk MAPKs was assessed by Western blot. All TLR agonists
induced the activation of p38 and Erk, as evidenced by increased
levels of phosphorylated p38 and Erk (Fig. 3A). The semi-
quantitative analysis showed that although increased phosphory-
lation of p38 and Erk were detected at 30 min, the maximum level
of phosphorylation was observed at 60 min post stimulation
(Fig. 3B). Together, these findings demonstrate that TLR ligand
stimulation induces p38 and Erk signaling in Muller glia, an
indication of their functional TLRs.
Muller glia produces inflammatory mediators in response
to TLR ligand and pathogen challenge
To assess the biological relevance of induced p38 and Erk
signaling and to further demonstrate the Muller glial responsive-
ness to different TLR ligands, we determined the effects of various
TLR ligands on the expression of proinflammatory cytokines using
RT-PCR. Compared to unstimulated controls, all TLR agonists
induced the expression of IL-6, IL-8, TNF-a, and IL-1b in MIO-
M1 cells (Fig. 4A). The mRNA levels of GAPDH (internal control)
remained largely unchanged in both control and stimulated cells.
The semi-quantitative analysis by measuring PCR product band
intensity revealed that the highest induction was observed for
TNF-a and IL-8 followed by IL-6. The mRNA levels of IL-1b
were significantly increased by TLR2 (Pam2) and TLR4 (LPS)
agonist compared to other ligands (Fig. 4B). The protein levels of
induced cytokines/chemokines were assessed by ELISA. Signifi-
cantly increased amounts of TNF-a, IL-1b, IL-6, and IL-8
accumulated in the culture media of stimulated MIO-M1 cells for
8 h (Fig. 5C). Consistent with RT-PCR data, Pam2 and LPS
induced the maximum secretion of IL-1b.
Previously, we showed that Muller glia secrete proinflammatory
mediators in response to S. aureus, a Gram-positive bacterium
challenge [18]. To assess, whether Muller glia can also respond to
other pathogens, we stimulated the MIO-M1 cells to Pseudomonas
aeruginosa, a Gram-negative bacterium and Candida albicans, a fungal
pathogen. As shown in the Figure 5, similar to S. aureus, Muller glia
expressed (Fig. 5A) and secreted increased levels of TNF-a (Fig. 5B)
and IL-6 (Fig. 5C) in response to P. aeruginosa and C. albicans. Taken
together, these results indicate that the Muller glia is responsive to
different TLR agonists and pathogens via the expression and
production of proinflammatory cytokines and chemokines.
The primary mouse Muller glia expresses functional TLRs
Although both in vivo (mouse retina) and in vitro (MIO-M1)
approaches confirmed the expression of TLRs in Muller glia, we
Figure 2. Induced TLR expression in Muller glia challenged with TLR ligands. MIO-M1 cells were left untreated (C) or stimulated with
indicated TLR ligands Pam2Cys (10 mg/ml), Poly(IC) (10 mg/ml), LPS (10 mg/ml), Flagellin (250 ng/ml), Poly(dT) (10 mM/ml), and ODN (10 mg/ml) for
4 h. Cells were lysed for Western blot analysis using specific anti-TLR and b-actin (control) antibodies (A). The band intensity was quantified by
densitometric analysis and presented as relative band intensity of TLR vs b-actin (B). Induced expression of TLRs was further confirmed by
immunostaining using indicated anti-TLR antibodies (C) and for quantitation, cells were stained for FACS analysis and presented as mean fluorescent
intensity (MFI) of respective TLR positive cells (D). The data shown are representative of duplicate experiments. The indicated p values (t-test) are
comparisons of unstimulated vs TLR agonist stimulated cells. Magnification 206.
doi:10.1371/journal.pone.0029830.g002
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Muller glia. To assess the identity of primary Muller glia, we first
used the RT-PCR and found that they express mRNA for Muller
cell markers, glial fibrillary acidic protein (GFAP), cellular
retinaldehyde binding protein (CRALBP), vimentin, nestin, S-15
and glutamine synthetase (GS). The expression levels of GFAP and
CRALBP were lower compared to others (Fig. 6A). Furthermore,
the expression of GFAP, CRALBP, vimentin and GS at protein
levelswasconfirmed byimmunostaining(Fig.6B).Next,weassessed
the TLR expression and observed the mRNA expression of the
mouse TLR1 to 9. Among all the TLRs, the mRNA expression of
TLR3, 5, and 9 was lower (Fig. 6C). The expression of selected
TLRs at protein levels was assessed by flowcytometry (Fig. 6D). To
test whether the expressed TLRs arefunctional, primary Muller glia
were stimulated with various TLR agonists and production of
inflammatory mediators was assessed by ELISA. Similar, to MIO-
M1 cells (Fig. 4), primary Muller glia were also found responsive to
TLR ligand challenge, as increased accumulation of mouse IL-6
and MIP-2 was detected in the culture media of stimulated cells
(Fig. 6E). Therefore, these findings provided confidence in
documenting TLR expression and function in the Muller glia.
Discussion
The limited immune surveillance of the retina makes it crucial
that resident cells be able to quickly recognize and respond to
invading pathogens in case of infectious endophthalmitis. We
hypothesized that Muller glia provides retinal innate defense in
endophthalmitis via the action of TLR signaling and recently
reported the expression of functional TLR2 [18]. Infectious
endophthalmitis can be caused by a wide variety of microorgan-
isms ranging from bacteria to fungi and each pathogen expresses
distinct PAMPs which are recognized by different TLRs.
Therefore, it is important to study Muller glial TLR expression
profile and their responsiveness to known TLR agonists. To our
knowledge, this is the first report describing the expression and
function of all known human TLR1–10 in retinal Muller glia. In
this study, we show that following stimulation with respective
ligands, Muller glia express increased levels of various TLRs and
triggered the activation of NF-kB, p38 and Erk MAPKs signaling.
Moreover, in response to TLR ligands and live pathogens
challenge, Muller glia produced various inflammatory cytokines
and chemokines, indicating the functionality of expressed TLRs.
Figure 3. TLR agonist stimulation activated NF-kB, p38 and ERK signaling in Muller glia. To detect the nuclear translocation of NF-kB p65,
MIO-M1cells were cultured for 60 min in the presence of indicated TLR ligands. Cells were then fixed, permeabilized, and immunostained with Ab
against p65 subunit of NF- kB( A). To assess the activation of p38 and ERK signaling, following TLR ligand stimulation for 30 and 60 min, MIO-M1cells
were lysed for Western blot analysis using antibodies against phospho-p38 (P-p38) and phospho-ERK (P-ERK). Antibodies against non-
phosphorylated p38 and ERK were used to detect their total levels, and Hsp-90 was used as an equal protein loading control (B). The band intensity
was quantified by densitometric analysis and presented as relative band intensity of TLR vs Hsp-90 (C). The indicated p values (one-way ANOVA) are
comparisons of stimulated cells at 0 min vs 30 and 60 min. MIO-M1 cells challenged with TLR ligands showed time-dependent manner activation of
p-38 and p-ERK signaling pathways. The data shown are representative of duplicate experiments.
doi:10.1371/journal.pone.0029830.g003
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the ability to recognize and respond to diverse infectious stimuli,
implicating their role in retinal innate immunity.
The discovery of TLRs, which have come to occupy the center
stage in innate immunity against invading pathogens, represent a
breakthrough in understanding host-pathogen interactions [25].
An increasing number of studies had shown that TLRs are
expressed by a variety of tissues and cells in the eye [10,26].
However, whether retinal Muller glia express various TLRs is not
known. We first tested our hypothesis by assessing TLR expression
in the mouse retina and showed that Muller glia were
immunoreactive to TLR2, 3, 4, 5, 7, and 9 antibodies. However,
due to the limitation of available antibodies and their affinities, we
could not perform the immunohistochemistry of all TLRs in
mouse tissue. Instead, we utilized the available human retinal
Muller glia cell line (MIO-MI1) and primary mouse retinal Muller
glia for in vitro experiments. Our studies revealed that they express
a large repertoire of TLR molecules comprised of TLR1–10 and
identified a number of interesting aspects of TLR biology in these
cells. The expression of a large set of TLRs suggests that Muller
glia have the ability to respond to many microbes that could be
encountered in infectious endophthalmitis. Unlike the ocular
surface, which is constantly exposed to environmental stimuli
including the pathogens, the intraocular compartment of the eye is
sterile. Hence, the sensitivity of Muller glia to TLR agonists may
be regulated by the level of specific TLR expression. To this end,
our western blot and flowcytomerty data showed that in response
to TLR ligand stimulation, Muller glia increased the TLR
Figure 4. TLR agonists induced expression and secretion of inflammatory mediators in Muller glia. MIO-M1 cells were stimulated with
indicated TLR ligands. After 4 h, total RNA was extracted, reverse transcribed, and amplified using specific primers (Table 1), with GAPDH as the
control. PCR products were separated by electrophoresis and stained with ethidium bromide (A). The band intensities of PCR products were
quantified by densitometric analysis and presented as relative band intensity of cytokines vs GAPDH. (B). In another experiment, MIO-M1cells were
challenged with TLR agonists for 8 h and secretion of indicated cytokine/chemokine were measured by ELISA (C). The amount of cytokines was
normalized with protein concentration of cell lysate (picograms per milligram cell lysate). One-way ANOVA was performed for statistical analysis of
induced expression of TNF-a (^p,0.01), IL-1b (
dp,0.05), IL-6(
dp,0.05), and IL-8 (
#p,0.05) in control vs various TLR agonist stimulated cells. Similar
analysis was performed for ELISA data (*p,0.05). The data shown are cumulative of three experiments performed in duplicate.
doi:10.1371/journal.pone.0029830.g004
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sensitivity of Muller glia to recognize microbes in infectious
endophthalmitis.
Since all TLRs were found to be expressed in Muller glia, for
which specific ligands were available, we accessed their functional
activity upon stimulation with the corresponding ligand. TLR-2
recognizes a variety of microbial products, such as peptidoglycan
(PGN) and lipoteichoic acid (LTA) from Gram-positive bacteria,
bacterial lipoproteins [27] and zymosan, a yeast cell wall
component [28]. Its wide range of ligand specificity may be
accountable for its ability to form heterodimers with TLR-1 [29]
and TLR-6 [30,31]. For example, TLR2/6 heterodimer recog-
nizes triacylated lipopeptides, whereas the TLR2/6 heterodimer
recognizes diacylated lipopeptides from bacteria. In our recent
study, we showed that TLR2 plays an important role in mediating
Muller glia innate response to S. aureus. We showed that TLR2
activation not only induced the production of inflammatory
mediators, but also increased the production of antimicrobial
peptides such as LL-37. Moreover, the culture media from TLR2-
activated Muller glia possess strong antibacterial activity, suggest-
ing the potential involvement of antimicrobial peptides [18]. In
this study, instead of Pam3Cys, a triacylated lipopeptide, we tested
the response of Muller glia by using Pam2Cys, which is a
diacylated lipopeptide. Taken together, our results indicate that
Muller glia express functional TLR1 and 6 and has the potential to
recognize both di and tri acylated lipopeptide, mainly from Gram-
positive and Gram-negative bacteria respectively. In addition to
Gram-positive bacteria, some previous studies have suggested the
role of TLR2 in recognition of C. albicans [32]. Thus, the
responsiveness of Muller glia to C. albicans does imply the potential
involvement of TLR2.
Lipopolysaccharide (LPS), a major virulence factor present on
the cell wall of Gram-negative bacteria is recognized by TLR4, the
first mammalian TLR to be characterized [33]. TLR4 signaling
requires a number of accessory proteins to initiate a signal. A key
component of the TLR4 receptor cluster is MD-2, which binds to
the extracellular domain of TLR4 and is essential for LPS
recognition [34]. Another important TLR4 accessory protein is
CD14, which upon binding to LPS, facilitates the transfer of LPS
to the TLR4/MD-2 complex. Studies have demonstrated that this
is particularly important in facilitating TLR4 responsiveness to
very low levels (,1 ng/ml) of LPS [35]. In addition, CD14 has
also been implicated in TLR-2 signaling, and studies have
demonstrated that CD14 can bind to lipoproteins [36] and
potentiate the activation of NF-kB following TLR2/1 ligation[37].
The expression of TLR4, MD2, and CD14 in Muller glia suggests
the existence of functional TLR4 machinery, which was
strengthened by our data that showed that these cells are
responsive to LPS challenge and P. aeruginosa, a Gram-negative
bacterium.
In addition to TLR2 and 4, the other receptors involved in
bacterial recognition are TLR5 and 9. TLR5 mediates the
recognition of flagellin, a flagellum component, present on many
motile bacteria [38]. We also previously reported the critical role
of TLR5 in corneal innate defense against Pseudomonas aeruginosa
keratitis [39,40]. Here, we show that stimulation of Muller glia
with either flagellin or live P. aeruginosa induces the production of
inflammatory mediators. Thus, TLR5 expression on Muller glial
cells may be critical in sensing the invasion of flagellated bacteria
into the vitreous cavity. TLR3, 7, and 9 belong to the nucleic
acid–sensing TLRs family, and they localize to various intracel-
lular compartments. TLR9 recognizes unmethylated 29-deoxyribo
(cytidine-phosphate-guanosine) (CpG) DNA motifs that are
frequently present in the bacterial and viral genome but are rare
in mammalian cells. TLR3 recognizes dsRNA whereas TLR7-
mediates recognition of ssRNA, and their activation initiates
antiviral responses. The expression of TLR3, 7, and 9 in Muller
glia and their activation with respective ligands implicates the role
of Muller glia in antiviral innate defense, potentially in viral
retinitis in AIDS patients [41]. Overall, our data suggests that
Figure 5. Muller glia expresses and secretes proinflammatory mediators in response to live pathogen challenge. MIO-M1 cells were
stimulated with S. aureus (Gram-positive bacteria), P. aeruginosa (Gram-negative bacteria), and C. albicans (fungi) for 4 h. At the end of the incubation
period, cells were used for RNA extraction followed by RT-PCR (A), whereas the culture supernatant was used for measurement of TNF-a (B), and IL-6
(C). The indicated statistical differences are comparisons of unstimulated (control) vs TLR agonist stimulated cells: *p,0.05 (one-way ANOVA).
doi:10.1371/journal.pone.0029830.g005
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associated molecular patterns (PAMPs) present on bacterial, fungal
and viral pathogens. Although, we recently reported that siRNA-
mediated knockdown of TLR2 attenuated the responsiveness of
Muller glia towards S. aureus [42], further studies are warranted to
ascertain the specific roles of TLR(s) in recognizing Gram-negative
bacteria and fungi. Moreover, in addition to TLRs, we cannot
exclude the possibility that other pattern recognition receptor
families, e.g. NOD-like receptors NLRs and retinoic acid-
inducible gene-I-like receptors (RLRs), may also play a role in
pathogen recognition by Muller glia.
Although the recognition of different ligands by specific TLRs
leads to activation of an intracellular signaling cascade in a
MyD88 dependent or independent fashion, all TLRs share NF-
kB signal transduction pathways to regulate many key proteins
participating in inflammation [10]. In retinal Muller glia,
activation of all TLRs by their respective ligands appears to
trigger a classical response characterized by a nuclear translo-
cation of the NF-kB p65 subunit, as evaluated by indirect
immunofluorescence. In addition to NF-kBa c t i v a t i o n ,T L R
ligands also induce the activation of other MAPKs, such as p38
and Erk, and these signaling molecules are known to contribute
towards the inflammatory response in cells [17]. Our data, that
TLR agonist induces the activation of p38, and Erk suggests
their involvement in Muller glial innate response to infectious
stimuli.
In conclusion, our findings show that Muller glia express
multiple TLRs, and TLR ligand treatments enhanced the
expression of respective TLRs, thus providing a mechanism to
potentate Muller glia activation prior to the infiltration of
leukocytes from the peripheral circulation (Fig. 7). Thus,
elucidation of the cellular pathways utilized by Muller glia in
Figure 6. Primary retinal Muller glia express TLRs and are responsive to TLR agonist challenge. The cultured primary retinal Muller glia
isolated from neonatal pups of C57BL/6 mice (see methods for detail) were analyzed for the expression of mRNAs encoding Muller cells markers using
RT-PCR (A) or for protein expression using immunostaining (B). The expression of TLRs 1–9 was assessed by RT-PCR (C) and flowcytometry (D). To
determine whether the expressed TLRs are functional, primary Muller glia were stimulated with indicated TLR agonists and secretion of mouse IL-6
and MIP-2 was quantitated by ELISA (E). The indicated statistical differences are comparisons of unstimulated (control) vs TLR agonist stimulated cells:
*p,0.05 (one-way ANOVA).
doi:10.1371/journal.pone.0029830.g006
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manipulate the intraocular immune response in endophthalmitis.
Materials and Methods
Ethical Statement
Mice were treated in compliance with the ARVO statement
for the Use of Animals in Ophthalmic and Vision Research, and
all procedures were approved by the Institutional Animal Care
and Use Committee of Wayne State University (protocol A- 09-
07-10).
Pathogens, TLR agonists, and antibodies
S. aureus (strain RN6390) and P. aeruginosa (ATCC 19660) were
maintained in tryptic soy broth (TSB; Sigma-Aldrich, St. Louis,
MO) whereas C. albicans (strain SC5314) was cultured on YPD
agar (Sigma-Aldrich, St. Louis, MO). Bacterial lipopeptide
Pam2Cys-Ser-(Lys)4 hydrochloride (Pam2Cys, TLR2 agonist),
polyI:C (TLR3 agonist), Lipoploysacchride (LPS, TLR4 agonist),
flagellin (TLR5 agonist), PolydT (TLR7/8 agonist), and ODN
(TLR9 agonist) were purchased from Invivogen (San Diego, CA).
Anti-phospho-p38 MAPK mAb, anti-p38 antibody, anti-phospho-
IkB-a, anti-IkB-a, anti-TLR2, and HSP-90 antibodies were
purchased from Cell Signaling Technology (Beverly, MA).
Antibodies against other TLRs were obtained from Santa Cruz
Biotechnology Inc (CA, USA). A mouse monoclonal anti-b-actin
antibody was purchased from Sigma-Aldrich (St. Louis, MO).
Secondary horseradish peroxidase (HRP)-conjugated anti-mouse
or anti-rabbit IgG antibodies were purchased from Bio-Rad
(Hercules, CA).
Muller glia cell line and primary culture
Spontaneously immortalized Human Muller Cell Line (MIO-
M1), kindly provided by Dr. G. Astrid Limb, were maintained in
DMEM (Hyclone, South Logan, UT) supplemented with
Glutamax (10%), FBS (10%), and antibiotic cocktail in a
humidified 5% CO2 incubator at 37uC. At the time of treatment,
the culture medium was replaced with antibiotic-free and growth-
factor-free fresh DMEM without phenol red (Hyclone, South
Logan). At the indicated times (as shown in figures), the cells were
processed for RNA extraction and protein preparation, whereas
the conditioned media were collected for cytokine assays.
Mouse primary retinal Muller glia were cultured from 2–3 day
old neonatal pups of C57BL/6 mice. Animals were euthanized
and their eyes enucleated. The globes were dissected and rinsed
with Hanks Balanced Salt Solution (HBSS), transferred into 2%
dispase, and placed in a 5% CO2 incubator at 37uC for 1 h.
Dispase activity was neutralized by washing the globes with low
glucose DMEM (Hyclone, South Logan, UT) supplemented with
10% FBS (BioAbchem, Ladson, SC). The anterior segment and
vitreous were excised, and the RPE layer was removed. The
retinas were transferred into DMEM containing 10% FBS and
triturated several times with a pipette. The dissociated cells were
transferred into 75 cm2 flasks and left to grow at 37uC for 3–4
days. After the mixed culture had grown confluent, the flasks were
subjected to mechanical shaking to remove loosely attached cells
primarily microglia. The cells, firmly attached to bottom,
consisting 90% Muller glia, were then cultured in 100 mm dishes
at a low density. Muller glia divided over the next two weeks to
form individual colonies of adherent cells. Individual cell clusters
comprised solely of Muller glia were trypsinized inside of a colony
Figure 7. Summary of retinal Muller glial innate response to infectious stimuli. (1) Retinal Muller cells are specialized glial cells, which span
through the entire thickness of the retina. Under normal conditions, they express Toll-like receptors (TLRs) at the basal level. (2) During trauma or
intraocular surgeries, the microbial pathogens or their products (e.g. LPS) gain access to vitreous cavity, where they activate Muller glial expressed
TLRs. (3) Binding of TLRs by its specific ligand (e.g. LPS for TLR4, S. aureus for TLR2 or bacterial CpG DNA by TLR9) leads to up-regulation of TLRs and
activates pro-inflammatory signaling cascade, leading to secretion of various inflammatory cytokines (IL-6, TNF-a), chemokines (IL-8), and
antimicrobial peptides (LL-37). (4) Muller glia released chemoattractants, such as IL-8 diffuse across retinal blood vessels and drive PMN infiltration
into the retina. While initiating phagocytosis to eliminate the invading microbial pathogens, infiltrated PMNs also release chemoattractants through
TLR activation by localized bacterial products to perpetuate PMN infiltration. The TLR-mediated secretion of antimicrobial peptides (LL-37) can
directly kill the invading pathogens. Thus, the Muller glia possesses the ability to sense infectious stimuli and initiate innate responses via the action
of TLR-signaling.
doi:10.1371/journal.pone.0029830.g007
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glia in this resulting culture exceeded .98%.
RNA extraction and RT-PCR analysis
Total RNA was isolated from MIO-M1 cells using the TRIzol
solution, following the manufacturer’s instructions (Invitrogen, Carls-
bad, CA) and 2 mg of total RNA was reverse-transcribed with a first-
strand synthesis system for RT-PCR (SuperScript; Invitrogen). cDNA
was amplified using human (Table 1) or mouse (Table 2) specific
primers. The PCR products and internal control GAPDH or b-actin
was subjected to electrophoresis on 1.2 % agarose gels containing
ethidium bromide. Stained gels were captured using a digital camera
(EDAS 290 system, Eastman Kodak, Rochester, NY), and band
intensity was quantified using Image J analysis software (NIH).
Flow cytometry analysis
MIO-M1 cells treated with or without ligands were dispensed in
eppendorf tubes and centrifuged at 100 g at 4uC for 5 min. Cells
were then resuspended in PBS containing 1% bovine serum
albumin (BSA). The cells were then blocked in 10% serum for
30 minutes at room temperature. The cells were then washed,
resuspended in PBS containing anti-TLR2, 3, 4, 5,7, and 9
antibodies (1:200 dilution) or isotype matched IgG (SantaCruz
Biotech, Santa Cruz, CA) (1:20 dilution) and were incubated
overnight at 4uC. Cells were washed and incubated with the
corresponding secondary FITC-conjugated antibody (Invitrogen)
(1:200 dilution) for 30 min. A BD LSR II flow cytometer
(Immunocytometry Systems, Becton and Dickinson, San Jose,
CA) was used for cytometric analysis.
Table 1. List of human primers used for RT-PCR analysis.
Gene Primer sequence Product Size (bp) Tm (6C)
TLR1 F: CTATACACCAAGTTGTCAGC
R: GTCTCCAACTCAGTAAGGTG
219 55
TLR2 F: GTGGCCAGCAGGTTCAGGATG
R: AGGACTTTATCGCAGCTCTCAG
641 55
TLR3 F: GATCTGTCTCATAATGGCTTG
R: GACAGATTCCGAATGCTTGTG
304 55
TLR4 F: TGGATACGTTTCCTTATAAG
R: GAAATGGAGGCACCCCTTC
506 55
TLR5 F: TAGCTCCTAATCTGATG
R: CCATGTGAAGTCTTTGCTGC
355 60
TLR6 F: CCTCAACCACATAGAAACGAC
R: CACCACTATACTCTCAACCCAA
531 55
TLR7 F: TCTACCTGGGCCAAAACTGTT
R: GGCACATGCTGAAGAGAGTTA
388 55
TLR8 F: GCCAGCGAGTCTCACTGAACT
R: GCCAGGGCAGCCAACATA
443 55
TLR9 F: GTCCCCACTTCTCCATG
R: GGCACAGTCATGATGTTGTTG
259 55
TLR10 F: TTATGACAGCAGAGGGTGATGC
R: CTGGAGTTGAAAAAGGAGGTTATAGG
151 55
CD14 F: CTCAACCTAGAGCCGTTTCT
R: CAGGATTGTCAGACAGGTCT
426 55
MD2 F: TATTGGGTCTGCAACTCAT
R: CTCCCAGAAATAGCTTCAAC
359 55
TRIF F: CTATAACTTTGTGATCCTC
R: GGTGTTGGCCACCTTCCT
399 55
TRAM F: GGCAAAGGGGATCCTTTCTCGGGGAA
R: GCACAGTGTGGATCCAAGTCCAGGATA
505 60
TRAF-6 F: TTCATAGTTTGAGCGTTATACCCGAC
R: CAGACTGATCAAGAATTGTAAGGCGTA
485 55
MyD88 F: TGCTGGAGCTGGGACCCAGCATTGAGGAGGA
R: TCAGACACACACAACTTCAGTCGATAG
503 55
TNF-a F: GAAAGCATGATCCGGGACGTG
R: GATGGCAGAGAGGAGGTTGAC
510 55
IL-1b F: AAACAGATGAAGTGCTCCTTCCAGG
R: TGGAGAACACCACTTGTTGCTCCA
390 55
IL-6 F: CTCCTTCTCCACAAGCGCCTTC
R: GCGCAGAATGAGATGAGTTGTC
583 55
IL-8 F: GCAGTTTTGCCAAGGAGTGCTA
R: GCATCTGGCAACCCTACAACAAG
347 55
GAPDH F: CACCACCAACTGCTTAGCAC
R: CCCTGTTGCTGTAGCCAAAT
515 55
doi:10.1371/journal.pone.0029830.t001
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MIO-M1 cell lysates were prepared with radioimmunopre-
cipitation assay (RIPA) buffer [150 mM NaCl, 100 mM Tris-
HCl, pH 7.5, 1% deoxycholate, 0.1% sodium dodecyl sulphate
(SDS), 1% Triton X-100, 50 mM NaF, 100 mM sodium
pyrophosphate, 3.5 mM sodium orthovanadate, proteinase
inhibitor cocktails (Sigma-Aldrich, St. Louis, MO), and 0.1
mM phenylmethylsulphonyl fluoride (PMSF)], and the protein
concentration was determined using the BCA assay (micro BCA;
Pierce, Rockford, IL). Proteins (30–40 mg/well) were separated
by sodium dodecyl sulphate–polyacrylamide gel electrophoresis
(SDS-PAGE) in Tris/glycine/SDS buffer (25 mM Tris, 250 mM
glycine and 0.1% SDS) and electro-blotted onto nitrocellulose
transfer membranes (Bio-Rad Laboratories, Hercules, CA). After
blocking for 1–2 h in phosphate-buffered saline with Tween-20
(PBST) (20 mM Tris-HCl, 150 mM NaCl and 0.5% Tween)
containing 5% non-fat milk, the blots were probed overnight at
4uC with the desired antibodies as described by the manufac-
turer (Cell Signaling Technology; Sigma Aldrich). NF-kB
activation was determined in terms of inhibitory IkB-a
phosphorylation and degradation using anti-IkB-a and anti
phospho-IkB-a antibodies. After washing three times in PBST,
membranes were incubated with secondary horseradish perox-
idase (HRP)-conjugated anti-mouse or anti-rabbit IgG antibodies
(Bio-Rad) for 1 h. After washing with PBST four times for
10 min each, proteins were visualized with Super signal reagents
from Pierce (Rockford, IL).
Enzyme-linked immunosorbent assay (ELISA) for cytokine
analysis
MIO-M1 cells were plated (5610
6 cells per well) in six-well
plates. After growth factor starvation, cells were challenged with
different TLR specific agonists viz Pam2 (TLR2/6), PolyI:C
(TLR3), LPS (TLR4), flagellin (TLR5), poly(dT) (TLR7/8) and
ODN (TLR9) for indicated time periods, and culture media were
collected for measurement of human TNF-a, IL-1b, IL-6, and IL-
8 by ELISA. The cells were lysed, and protein concentration was
determined. ELISAs were performed according to the manufac-
turer’s instructions (R&D Systems, Minneapolis, MN). The
amount of cytokines in the culture media was expressed as
picograms per mg of cell lysate.
Immunoflourescence staining
Retinal cryo-sections were rinsed in PBS and blocked for 1 h in
blocking buffer [10% (vol./vol.) normal goat serum, 0.3% (vol./
vol.) triton X-100 in PBS] at room temperature. The slides were
then incubated overnight with anti-TLR2, 3, 4, 5, 7 and 9 (Santa
Cruz) or anti vimentin (Sigma Aldrich) antibody at 4uC. Following
removal of the primary antibodies, slides were extensively washed
and incubated for 1 h in fluorescent-conjugated secondary
antibodies (FITC) at room temperature. After several washing
steps in PBS, the slides were mounted in Vectashield anti-fade
mounting medium (Vector Laboratories, Burlingame, CA, USA)
and visualized using a confocal system (Leica Microsystems,
Wetzlar, Germany).
For in vitro staining, MIO-M1 cells cultured on glass chamber
slides (Fisher Scientific, Rochester, NY) were stimulated with
different TLR ligands for indicated time periods. The cells were
washed three times with phosphate-buffered saline (PBS) and then
fixed for 15 min in PBS with 4% paraformaldehyde. After washing
with gentle shaking, the cells were permeabilized for 5 min with
ice-cold methanol and washed. The fixed cells were then blocked
in 5% (wt/vol) serum for 1 h at room temperature followed by
incubation with TLR2, 3, 4, 5, 7 and 9 (Santa Cruz, CA) (1:200
dilution) antibodies overnight at 4uC. In control experiments, cells
were incubated with non-immune IgG as isotype controls (Santa
Cruz). Following removal of the primary antibodies, the cells were
then extensively washed with PBS and incubated for 1 h with
specific fluorescein isothiocyanate (FITC/Rhodamine)-conjugated
secondary antibodies (1: 200 dilution) at room temperature.
Finally, the cells were washed extensively with PBS, and the slides
were mounted in Vectashield anti-fade mounting medium (Vector
Laboratories) and visualized using a confocal system (Leica
Microsystems).
Statistics
All values were expressed as mean 6 standard deviation (SD).
The statistical analysis was performed using an unpaired t-test for
comparison of two groups whereas one-way analysis of variance
(ANOVA) was performed for multiple group comparisons (Prism;
GraphPad Software). p values less than 0.05 were considered
significant.
Table 2. List of mouse primers used for RT-PCR analysis.
Gene Primer sequence
Product
Size (bp) Tm (6C)
TLR1 F: GTTGTCACTGATGTCTTCAGC
R: CTGTACCTTAGAGAATTCTG
319 55
TLR2 F: TGCTTTCCTGCTGGAGATTT
R: TGTAACGCAACAGCTTCAGG
196 55
TLR3 F: CAGTTCAGAAAGAACGG
R: AGCCTTATACCATAAAAGC
614 55
TLR4 F: TTGTCTTCTGCACGAACCTG
R: GGCAACGCAAGGATTTTATT
311 55
TLR5 F: GGTGGTGGTGGGATCGCTGTC
R: CCAGGGAAGGACCCCCAGCG
295 55
TLR6 F: AGTGCTGCCAAGTTCCGACA
R: AGCAAACACCGAGTATAGCG
527 55
TLR7 F: TCTTACCCTTACCATCAACCACA
R: CCCCAGTAGAACAGGTACACA
111 55
TLR8 F: CTTTCCAGCACTTCCCTCAG
R: GAAGACGATTTCGCCAAGAG
459 55
TLR9 F: TGAAGTCTGTACCCCGTTTCT
R: GTGGACGAAGTCGGAGTTGT
106 55
GFAP F: CACGAACGAGTCCCTAGAGC
R: ATGGTGATGCGGTTTTCTTC
234 60
CRALBP F: TACCCTGGTGTCCTTTCCAG
R: GGTTTCCTCATTTTCCAGCA
150 63
Vimentin F: ATGCTTCTCTGGCACGTCTT
R: AGCCACGCTTTCATACTGCT
206 64
Nestin F: AACTGGCACACCTCAAGATGT
R: TCAAGGGTATTAGGCAAGGGG
235 60
S-15 F: TTCCGCAAGTTCACCTACC
R: CGGGCCGGCCATGCTTTACG
361 60
GS F: CCACCTCAGCAAGTTCCCACTT
R: TCAGACCATTCTCCTCCCGCAT
797 55
b-actin F: CTTCTTTGCAGCTCCTTCGT
R: GTGCCAGATCTTCTCCATGT
310 55
GAPDH F: TCATTGACCTCAACTACATGGT
R: CTAAGCAGT TGGTGGTGCAG
442 55
doi:10.1371/journal.pone.0029830.t002
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